Item 1.01. Entry into a Material Definitive Agreement.
As disclosed previously, on January 4, 2023, Addentax Group Corp. (the
"Company") entered into a Securities Purchase Agreement (the "Original Purchase
Agreement") with certain accredited investors identified therein (the
"Investors") relating to a private placement by the Company of (1) senior
secured convertible notes in the aggregate principal amount of $$16,666,666.66,
and (2) warrants to purchase up to 16,077,172 shares of common stock of the
Company, exercisable for a period of five years at an exercise price of $1.25,
for consideration of a net proceed of $15,000,000 payable by the Investors to
the Company.
On January 10, 2023, the Company entered into an amendment (the "Amendment", and
the Original Purchase Agreement, as amended, the "Purchase Agreement") to the
Original Purchase Agreement with each Investor in accordance with the terms of
the Original Purchase Agreement. Under the Amendment, the original increase in
the authorized shares of the Company from 50,000,000 to 150,000,000 was
increased to 250,000,000.
The foregoing summary of the Amendment does not purport to be complete and is
subject to, and qualified in its entirety by, the full text of the Amendment,
the form of which is filed as Exhibit 10.1 to this report and is incorporated
herein by reference.
Item 9.01. Exhibits
(d) Exhibits.
Exhibit Number Description
10.1 Form of Amendment No. 1 to Securities Purchase Agreement
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
© Edgar Online, source Glimpses